Myriad Genetics (MYGN) Other Non Operating Income (2009 - 2025)

Myriad Genetics (MYGN) has 17 years of Other Non Operating Income data on file, last reported at $400000.0 in Q4 2025.

• Other Non Operating Income for Q4 2025 came in at $400000.0, up 33.33% year-over-year; the trailing twelve-month figure through Mar 2026 was $700000.0 (up 200.0% YoY), and the FY2025 annual result was $800000.0, down 27.27% from the prior year.
• Other Non Operating Income held at $400000.0 in Q4 2025 per MYGN's latest filing, from $400000.0 in the prior quarter.
• Over five years, Other Non Operating Income peaked at $120.6 million in Q3 2021 and troughed at -$2.4 million in Q2 2023.
• A 5-year average of $8.1 million and a median of $100000.0 in 2022 frame the typical range for Other Non Operating Income.
• The sharpest annual moves came in 2021 and 2023: Other Non Operating Income jumped 7637.5% in 2021, then tumbled 2500.0% in 2023.
• A 5-year view of Other Non Operating Income shows it stood at $120.6 million in 2021, then sank by 99.59% to $500000.0 in 2022, then sank by 240.0% to -$700000.0 in 2023, then jumped by 142.86% to $300000.0 in 2024, then soared by 33.33% to $400000.0 in 2025.
• Business Quant data shows MYGN's Other Non Operating Income at $400000.0 in Q4 2025, $400000.0 in Q3 2025, and -$100000.0 in Q2 2025.